hotspot -WSS

hotspot

author：fashion 2025-09-28 01:37:39 - browse：24

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Rise in cancer among younger people worries and puzzles doctors

Wikipedia

WSS

CDC recommends RSV monoclonal antibody for infants

STAT Report: Patient voices and perspectives

Biogen says it will cut costs by $700 million, slash 1,000 jobs

STAT Report: Patient voices and perspectives

Senate panel puts off hardest PBM reforms for another day

Flint parents haunted by uncertainty, fears of lead poisoning

hotspot

hotspot

focus

Medical records are filled with copy

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Report: Patient voices and perspectives

United colonoscopy coverage change 'may cost lives,' doctors say

Why patients can’t get everything they want on drug pricing

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Former reverend arrested for allegedly killing 8

Peter Hotez and the public health issue of online harassment

FDA scientists endorse Pfizer/BioNTech Covid

focus

Democrats decry new health bill for going easy on private equity

Chris Christie meets with Zelenskyy during Ukraine trip

Flint parents haunted by uncertainty, fears of lead poisoning

Pharma showers House GOP doctor with campaign cash

Dems pitch expanding Medicare power to negotiate drug prices

Device maker Teleflex to acquire urology company for $600M

hotspot

Wikipedia

explore

entertainment